Recently Viewed
Clear AllQuality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$1 Mln
Revenue (TTM)
$-- Mln
Net Profit (TTM)
$-- Mln
ROE
-0.1 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
0
Industry P/E
--
EV/EBITDA
0.3
Div. Yield
0 %
Debt to Equity
0.2
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
563,338
CFO
$21.53 Mln
EBITDA
$35.40 Mln
Net Profit
$19.13 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Universe Pharmaceuticals Inc (UPC)
| -21.3 | 10.3 | -21.3 | 4.9 | -61.5 | -63.6 | -- |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2023
|
2022
|
|---|---|---|---|
|
Universe Pharmaceuticals Inc (UPC)
| 524.6 | -76.9 | -11.3 |
|
S&P Small-Cap 600
| 4.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Universe Pharmaceuticals Inc (UPC)
|
3.0 | 1.5 | 17.9 | -3.7 | -- | -7.2 | -- | 0.0 |
| 0.9 | 6.8 | 0.0 | -4.3 | -- | -18.6 | -- | 0.4 | |
| 1.3 | 13.2 | 18.7 | -2.0 | 25.4 | -3.9 | -- | 0.2 | |
| 16.0 | 785.8 | 107.5 | 105.9 | -1.8 | 44.8 | 7.4 | 2.7 |
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common... chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited. Address: 265 Jingjiu Avenue, Ji'An, China, 343100 Read more
CEO & Chairman
Mr. Gang Lai
CEO & Chairman
Mr. Gang Lai
Headquarters
Ji'An
Website
The share price of Universe Pharmaceuticals Inc (UPC) is $3.00 (NASDAQ) as of 02-Apr-2026 11:15 EDT. Universe Pharmaceuticals Inc (UPC) has given a return of -61.45% in the last 3 years.
Since, TTM earnings of Universe Pharmaceuticals Inc (UPC) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
--
|
--
|
|
2024
|
--
|
--
|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
The 52-week high and low of Universe Pharmaceuticals Inc (UPC) are Rs 11.00 and Rs 2.00 as of 02-Apr-2026.
Universe Pharmaceuticals Inc (UPC) has a market capitalisation of $ 1 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Universe Pharmaceuticals Inc (UPC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.